|
17 Jun 2021 |
FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease
|
|
17 Jun 2021 |
Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License Agreement with Sanofi for Ataciguat
|
|
17 Jun 2021 |
Debiopharm and Ubix Therapeutics Launch Research to Develop a New Anti-Cancer Modality - Antibody Degraducer® Conjugates
|
|
17 Jun 2021 |
Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease
|
|
15 Jun 2021 |
CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia
|
|
10 Jun 2021 |
Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors
|
|
10 Jun 2021 |
Caraway Therapeutics Establishes Collaboration with AbbVie to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders
|
|
04 Jun 2021 |
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology
|
|
03 Jun 2021 |
Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer
|
|
03 Jun 2021 |
Proteros Enters Into Oncology Collaboration and License Agreement With AstraZeneca
|
|
02 Jun 2021 |
MorphoSys to Acquire Constellation Pharmaceuticals
|
|
01 Jun 2021 |
Heartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure
|
|
27 May 2021 |
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
|
|
26 May 2021 |
Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine
|
|
26 May 2021 |
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
|
|
25 May 2021 |
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
|
|
20 May 2021 |
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
|
|
19 May 2021 |
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
|
|
18 May 2021 |
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases
|
|
14 May 2021 |
Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research
|
|
12 May 2021 |
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
|
|
11 May 2021 |
Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
|
|
11 May 2021 |
Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders
|
|
05 May 2021 |
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy
|
|
04 May 2021 |
UPPTHERA and ComInnex sign research collaboration for the development of novel Proteolysis-Targeting Chimera candidates
|
